Artificial Cells Nanomedicine and Biotechnology · 2019 · 37 citations · 35 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryOral Drug DeliveryDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanoparticle DesignNanoparticle FormulationsOral NanocarriersDrug Delivery NanocarriersNanoparticle Cellular UptakeOral Drug Delivery FormulationsOral Drug Delivery NanoparticlesOral Drug Delivery SystemsPolymer NanocarriersPolymeric Nanoparticle FormulationRate-limiting Absorption
Introduction Indinavir (IDV) is a potent HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV). IDV is a weak base with limited aqueous solubility in its unprotonated form; therefore, solubility of IDV in the gastrointestinal tract fluids is the rate-limiting step of its absorption and onset of action. However, in many cases, drugs are not absorbed well in the gastrointestinal tract; polymer nanoparticles were recognized as an effective carrier system for drug encapsulation and are now studied as a vehicle for oral delivery of insoluble compounds. Preparation of methoxy poly (ethylene glycol)-poly (e-caprolactone) (mPEG-PCL) nanoparticles is among the strategies to overcome low bioavailability of drugs with poor aqueous solubility.Materials and method The structure of the copolymers was characterized using 1H NMR, FTIR, DSC and GPC techniques. IDV loaded mPEG- PCL nanoparticles prepared by emulsification solvent evaporation method were optimized using D-optimal experimental design and were characterized by various techniques such as DLS, DSC, XRD, AFM and SEM. Using Caco-2 cells as a cellular model, we studied the cellular uptake and transport.Results In vivo pharmacokinetic studies were performed in rats. The plasma AUC (0–t), t1/2 and Cmax of IDV-mPEG-PCL NPs were increased by 5.30, 5.57 and 1.37 fold compared to the IDV solution, respectively.Conclusion The results of this study are promising for the use of biodegradable polymeric nanoparticles to improve oral drug delivery.
35
Biodegradable Long-Circulating Polymeric Nanospheres
Ruxandra Gref, Yoshiharu Minamitake, Maria Teresa Peracchia et al. · Science · 1994 · 2.9K citations